<DOC>
	<DOC>NCT01704196</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.</brief_summary>
	<brief_title>A Multi-Center Trial of Nepicastat for Cocaine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Be at least 18 years of age Is seeking treatment for cocaine dependence Is able to understand and provide written informed consent Has completed all psychological assessments and procedures required during the 7 14 day screening period If female, agrees to use an acceptable method of birth control Is, in the opinion of the Investigator, likely to complete the 11week Treatment Phase of the study Please contact the study site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>